That can be part of Plan A.
What's the revenue potential for CA and EU, vs USA? And how much sooner can they get to CE? Time, features and tasks cost money.
If the design freeze contains 90% of what the FDA requires, or close - the company doesn't need to go for further delusion.
Once there is a market value because of CE mark, and a revenue vehicle as a marketable product then there will be a pps multiple. Further, once pps is above the minimum requirements, then Titan must move ASAP to uplist and get further mileage. That has to be a focus for mgmt too.
You have to get to a viable launch point, then go beyond. I think reaching for a bigger target audience may be a bridge too far because of past mistakes. It may not be as big an issue if funding becomes available, but that's a big TBD. It's time to get the most expeditious plan in place to build confidence.
Regards,
BK
News 
Market Data 
Discover 
AI
